Articles related to OPIOIDS

“The death of almost one million Americans during the opioid epidemic has been one of the cardinal failures of the public health establishment,” said FDA Commissioner Marty Makary, M.D., M.P.H. “This long-overdue labeling change is only part of what needs to be done — we also need to modernize our approval processes and post-market monitoring so that nothing like this ever happens again.”

With more potent forms of opioids on the street, overdoses from illicit drugs are at an all-time high and withdrawal from them is often more severe.

Suzetrigine, a newly approved NaV1.8 inhibitor, offers a promising non-opioid alternative for managing moderate-to-severe acute pain, backed by robust clinical trial data.

High doses of loperamide, an OTC antidiarrheal, are being abused for opioid-like effects, leading to severe cardiac risks. Clinicians should screen for loperamide toxicity in patients with a history of opioid use presenting with related symptoms.

This case serves as a stark reminder of the potential dangers of opioid prescription, particularly in patients with conditions like sleep apnea.

This case serves as a stark reminder of the potential consequences of incomplete patient history taking and inadequate monitoring. It underscores the need for healthcare professionals to be thorough and vigilant when prescribing potent medications like opioids.